171.56
price down icon1.23%   -2.14
after-market Dopo l'orario di chiusura: 171.60 0.04 +0.02%
loading
Precedente Chiudi:
$173.70
Aprire:
$172.88
Volume 24 ore:
6.73M
Relative Volume:
1.19
Capitalizzazione di mercato:
$303.17B
Reddito:
$55.53B
Utile/perdita netta:
$5.12B
Rapporto P/E:
59.57
EPS:
2.88
Flusso di cassa netto:
$15.62B
1 W Prestazione:
-2.06%
1M Prestazione:
-2.18%
6M Prestazione:
-2.12%
1 anno Prestazione:
+5.88%
Intervallo 1D:
Value
$171.27
$173.99
Intervallo di 1 settimana:
Value
$168.72
$177.98
Portata 52W:
Value
$153.58
$207.32

Abbvie Inc Stock (ABBV) Company Profile

Name
Nome
Abbvie Inc
Name
Telefono
(847) 932-7900
Name
Indirizzo
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Name
Dipendente
50,000
Name
Cinguettio
@abbvie
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
ABBV's Discussions on Twitter

Confronta ABBV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
ABBV
Abbvie Inc
171.56 303.17B 55.53B 5.12B 15.62B 2.88
Drug Manufacturers - General icon
LLY
Lilly Eli Co
725.72 689.73B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
78.69 349.44B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
147.03 344.63B 87.70B 14.68B 19.03B 6.05
Drug Manufacturers - General icon
MRK
Merck Co Inc
97.92 251.88B 63.17B 12.15B 14.84B 4.77

Abbvie Inc Stock (ABBV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-10 Ripresa BofA Securities Neutral
2024-12-05 Downgrade Daiwa Securities Outperform → Neutral
2024-11-22 Aggiornamento Leerink Partners Market Perform → Outperform
2024-11-15 Iniziato Wolfe Research Outperform
2024-11-04 Aggiornamento Argus Hold → Buy
2024-10-17 Iniziato Bernstein Mkt Perform
2024-06-05 Aggiornamento HSBC Securities Hold → Buy
2024-05-17 Iniziato Cantor Fitzgerald Overweight
2024-01-29 Aggiornamento William Blair Mkt Perform → Outperform
2023-12-18 Downgrade HSBC Securities Buy → Hold
2023-12-11 Aggiornamento Goldman Neutral → Buy
2023-11-09 Iniziato Deutsche Bank Hold
2023-10-30 Aggiornamento Barclays Equal Weight → Overweight
2023-10-20 Ripresa UBS Neutral
2023-09-29 Iniziato Raymond James Outperform
2023-07-25 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Buy
2023-04-05 Downgrade Argus Buy → Hold
2023-03-01 Iniziato Guggenheim Buy
2023-02-22 Downgrade Wolfe Research Outperform → Peer Perform
2023-02-10 Aggiornamento SVB Securities Underperform → Market Perform
2022-11-18 Iniziato Credit Suisse Outperform
2022-11-08 Downgrade Societe Generale Buy → Hold
2022-08-01 Downgrade Atlantic Equities Overweight → Neutral
2022-05-23 Iniziato SVB Leerink Underperform
2022-05-06 Downgrade Daiwa Securities Outperform → Neutral
2022-04-06 Ripresa Morgan Stanley Overweight
2022-02-28 Downgrade UBS Buy → Neutral
2022-02-03 Reiterato BMO Capital Markets Outperform
2022-02-03 Reiterato Barclays Equal Weight
2022-02-03 Reiterato BofA Securities Neutral
2022-02-03 Reiterato Goldman Neutral
2022-01-13 Iniziato Redburn Buy
2022-01-12 Reiterato BMO Capital Markets Outperform
2021-12-09 Ripresa Wells Fargo Overweight
2021-11-23 Aggiornamento Societe Generale Hold → Buy
2021-07-27 Ripresa Truist Buy
2021-04-07 Ripresa RBC Capital Mkts Outperform
2020-11-10 Ripresa Bernstein Outperform
2020-09-29 Iniziato Berenberg Hold
2020-06-23 Aggiornamento Atlantic Equities Neutral → Overweight
2020-06-09 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-06-02 Aggiornamento Argus Hold → Buy
2020-05-18 Ripresa BofA/Merrill Neutral
2020-05-12 Aggiornamento JP Morgan Neutral → Overweight
2020-05-11 Ripresa Morgan Stanley Overweight
2020-04-20 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2020-03-23 Downgrade Societe Generale Buy → Hold
2020-02-27 Iniziato Barclays Equal Weight
2020-02-06 Iniziato Mizuho Buy
2020-01-07 Iniziato RBC Capital Mkts Sector Perform
2019-12-26 Reiterato Cowen Outperform
2019-09-26 Aggiornamento Citigroup Neutral → Buy
2019-08-20 Aggiornamento Piper Jaffray Neutral → Overweight
2019-06-27 Aggiornamento Wolfe Research Underperform → Peer Perform
2019-06-26 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-05-28 Iniziato Goldman Neutral
2019-04-29 Aggiornamento BMO Capital Markets Underperform → Market Perform
Mostra tutto

Abbvie Inc Borsa (ABBV) Ultime notizie

pulisher
09:55 AM

Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.

09:55 AM
pulisher
07:54 AM

AbbVie Inc. (ABBV): A Bull Case Theory - Insider Monkey

07:54 AM
pulisher
06:27 AM

Diversify Advisory Services LLC Sells 6,472 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

06:27 AM
pulisher
05:28 AM

Artemis Investment Management LLP Has $85.98 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

05:28 AM
pulisher
05:28 AM

Brady Martz Wealth Solutions LLC Takes Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

05:28 AM
pulisher
04:30 AM

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Ameritas Advisory Services LLC - MarketBeat

04:30 AM
pulisher
Jan 19, 2025

AbbVie Inc. (NYSE:ABBV) Shares Bought by Wealth Alliance Advisory Group LLC - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Jackson Square Capital LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Cohen Klingenstein LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Avanza Fonder AB Acquires Shares of 8,443 AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 19, 2025
pulisher
Jan 18, 2025

AbbVie Inc. (NYSE:ABBV) Short Interest Update - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks? - Insider Monkey

Jan 18, 2025
pulisher
Jan 18, 2025

AbbVie Inc. (NYSE:ABBV) Position Raised by Lake Street Private Wealth LLC - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

AbbVie's SWOT analysis: stock outlook amid Humira erosion and pipeline growth - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Brooklyn Investment Group Has $2.73 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Householder Group Estate & Retirement Specialist LLC Reduces Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Wedge Capital Management L L P NC Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Channel Wealth LLC Has $1.68 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Yarger Wealth Strategies LLC - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

AbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by KMG Fiduciary Partners LLC - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt - Benzinga

Jan 17, 2025
pulisher
Jan 17, 2025

Two more AbbVie drugs put on the Medicare negotiation list - Crain's Chicago Business

Jan 17, 2025
pulisher
Jan 17, 2025

AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Decker Retirement Planning Inc. Purchases New Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

AbbVie stock target cut, keeps Buy rating on growth outlook - Investing.com

Jan 17, 2025
pulisher
Jan 17, 2025

FY2024 Earnings Forecast for AbbVie Issued By Zacks Research - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Tallon Kerry Patrick Buys New Shares in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Mason & Associates Inc Acquires 1,499 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Giant-Cell Arteritis Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA, and Developments | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys - Barchart

Jan 16, 2025
pulisher
Jan 16, 2025

Why the Market Dipped But AbbVie (ABBV) Gained Today - Yahoo Finance

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jan 16, 2025
pulisher
Jan 16, 2025

BMO maintains AbbVie stock Outperform rating - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie's Quarterly Earnings Preview: What You Need to Know - Nasdaq

Jan 16, 2025
pulisher
Jan 16, 2025

Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimila - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie and Simcere Join Forces for Multiple Myeloma Breakthrough - Zenopa

Jan 16, 2025
pulisher
Jan 16, 2025

Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge - Yahoo Finance

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie retains Humira market share above 70%: report - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie retains Humira market share amid biosimilars (ABBV:NYSE) - Seeking Alpha

Jan 16, 2025
pulisher
Jan 16, 2025

JPM25 Day 3: AbbVie, Gilead, GSK and Dyne - BioSpace

Jan 16, 2025
pulisher
Jan 16, 2025

JPM Day 3: AbbVie, Gilead, GSK and Dyne - PharmaLive

Jan 16, 2025
pulisher
Jan 16, 2025

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson - BioPharma Dive

Jan 16, 2025
pulisher
Jan 16, 2025

Future Industry Growth Of Antiviral Drugs Market by 2024 To 2031 | AbbVie Inc., GSK plc, Dr. Reddy's - EIN News

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie Inc. (NYSE:ABBV) Shares Purchased by BluePath Capital Management LLC - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Sawyer & Company Inc Sells 3,161 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Psoriasis Drugs Market Growth Drivers, Revenue, and Size - openPR

Jan 16, 2025
pulisher
Jan 16, 2025

Wolff Wiese Magana LLC Acquires 1,750 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Meyer Handelman Co. Has $27.52 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Radnor Capital Management LLC Has $4.38 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

AbbVie's Quarterly Earnings Preview: What You Need To Know - Barchart

Jan 16, 2025
pulisher
Jan 16, 2025

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance

Jan 16, 2025
pulisher
Jan 15, 2025

JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole - Yahoo Finance

Jan 15, 2025

Abbvie Inc Azioni (ABBV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general JNJ
$147.03
price down icon 0.50%
drug_manufacturers_general NVO
$78.69
price down icon 5.27%
drug_manufacturers_general MRK
$97.92
price down icon 2.76%
drug_manufacturers_general NVS
$97.53
price down icon 0.34%
drug_manufacturers_general PFE
$26.30
price down icon 0.72%
Capitalizzazione:     |  Volume (24 ore):